Aims: Nobiletin, a natural polymethoxylated flavonoid compound, has various beneficial properties, such as anticancer, anti-inflammatory, and antioxidant effects, and it also improves memory. Therefore, we investigated the effects and mechanisms of nobiletin on rat isolated mesenteric arteries (MAs). Methods: We examined vasodilation induced by nobiletin on rat isolated MA rings with a tension study, the expression and activity of endothelial nitric oxide synthase (eNOS) with Western blotting, NO production with DAF- FMDA fluorescence, and intracellular Ca2+ concentration ([Ca2+]i) with Fluo-3AM. Results and Conclusion: Our study showed that nobiletin elicited a dose-dependent vasodilation in phenylephrine precontracted MA rings, but it did not elicit the same response in pulmonary artery rings. Vasodilation was related to endothelium and activated partly by eNOS. Vasodilation was inhibited by denudation of the endothelium or inhibition of eNOS activity. Nobiletin increased NO production by promoting the phosphorylation of eNOS at Ser-1177 without changing the level of eNOS expression in rat mesenteric artery endothelial cells (RMAECs). Nobiletin increased the concentration of endothelial [Ca2+]i, which enhances eNOS activity in RMAECs. In summary, vasodilation induced by nobiletin was dependent on the endothelium and partly on eNOS activation, which is mediated by high endothelial [Ca2+]i. Results suggest nobiletin may offer a therapeutic benefit and could potentially be used as a vasodilator for the treatment of hypertension.

Keywords:
Nobiletin, Mesenteric artery, Vasodilation, Nitric oxide synthase, Extracellular Ca2+
1.
Adela R, Banerjee SK: GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. J Diabetes Res 2015;2015:490842.
2.
Mendis S, Puska P, Norrving B (eds): Global Atlas on Cardiovascular Disease Prevention and Control. Geneva, World Health Organization, 2011.
3.
Knekt P, Järvinen R, Seppänen R, Heliövaara M, Teppo L, Pukkala E, Aromaa A: Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997;146:223-230.
4.
Li S, Yu H, Ho CT: Nobiletin: efficient and large quantity isolation from orange peel extract. Biomed Chromatogr 2006;20:133-138.
5.
Nogata Y, Sakamoto K, Shiratsuchi H, Ishii T, Yano M, Ohta H: Flavonoid composition of fruit tissues of citrus species. Biosci Biotechnol Biochem 2006;70:178-192.
6.
Kimura J, Nemoto K, Degawa M, Yokosuka A, Mimaki Y, Shimizu K, Oku N, Ohizumi Y: Upregulation of N-methyl-D-aspartate receptor subunits and c-Fos expressing genes in PC12D cells by nobiletin. Biol Pharm Bull 2014;37:1555-1558.
7.
He Z, Li B, Rankin GO, Rojanasakul Y, Chen YC: Selecting bioactive phenolic compounds as potential agents to inhibit proliferation and VEGF expression in human ovarian cancer cells. Oncol Lett 2015;9:1444-1450.
8.
Hsiao PC, Lee WJ, Yang SF, Tan P, Chen HY, Lee LM, Chang JL, Lai GM, Chow JM, Chien MH: Nobiletin suppresses the proliferation and induces apoptosis involving MAPKs and caspase-8/-9/-3 signals in human acute myeloid leukemia cells. Tumour Biol 2014;35:11903-11911.
9.
Luo G, Guan X, Zhou L: Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biol Ther 2008;7:966-973.
10.
Chen C, Ono M, Takeshima M, Nakano S: Antiproliferative and apoptosis-inducing activity of nobiletin against three subtypes of human breast cancer cell lines. Anticancer Res 2014;34:1785-9172.
11.
Ma X, Jin S, Zhang Y, Wan L, Zhao Y, Zhou L: Inhibitory effects of nobiletin on hepatocellular carcinoma in vitro and in vivo. Phytother Res 2014;28:560-567.
12.
Kawabata K, Murakami A, Ohigashi H: Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells. Biosci Biotechnol Biochem 2005;69:307-314.
13.
Kandaswami C, Perkins E, Soloniuk DS, Drzewiecki G, Middleton E Jr: Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett 1991;56:147-152.
14.
Miyata Y, Sato T, Imada K, Dobashi A, Yano M, Ito A: A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochem Biophys Res Commun 2008;366:168-173.
15.
Lam KH, Alex D, Lam IK, Tsui SK, Yang ZF, Lee SM: Nobiletin, a polymethoxylated flavonoid from citrus, shows anti-angiogenic activity in a zebrafish in vivo model and HUVEC in vitro model. J Cell Biochem 2011;112:3313-3321.
16.
Kunimasa K, Ikekita M, Sato M, Ohta T, Yamori Y, Ikeda M, Kuranuki S, Oikawa T: Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo. Cancer Sci 2010;101:2462-2469.
17.
Zhou CH, Wu XH, Wu YQ: Nobiletin, a dietary phytochemical, inhibits vascular smooth muscle cells proliferation via calcium-mediated c-Jun N-terminal kinases pathway. Eur J Pharmacol 2009;615:55-60.
18.
Kyu-Tae Kang: Endothelium-derived relaxing factors of small resistance arteries in hypertension. Toxicol Res 2014;30:141-148.
19.
Billaud M, Lohman AW, Johnstone SR, Biwer LA, Mutchler S, Isakson BE: Regulation of cellular communication by signaling microdomains in the blood vessel wall. Pharmacol Rev 2014;66:513-569.
20.
Shi Y, Wu Z, Cui N, Shi W, Yang Y, Zhang X, Rojas A, Ha BT, Jiang C: PKA phosphorylation of SUR2B subunit underscores vascular KATP channel activation by beta-adrenergic receptors. Am J Physiol Regul Integr Comp Physiol 2007;293:R1205-R1214.
21.
Suvorava T, Nagy N, Pick S, Lieven O, Ruether U, Dao VT, Fischer J, Weber M, Kojda G: Impact of eNOS-dependent oxidative stress on endothelial function and neointima formation. Antioxid Redox Signal 2015;23:711-723.
22.
Pereira AC, Paulo M, Araujo A: Nitric oxide synthesis and biological functions of nitric oxide released from ruthenium compounds. Braz J Med Biol Res 2011;44:947-957.
23.
Bahna SL: Should exhaled nitric oxide measurement be part of routine asthma management. Ann Allergy Asthma Immunol 2012;109:289-291.
24.
Wang JH, Cheng J, Li CR, Ye M, Ma Z, Cai F: Modulation of Ca2+ signals by epigallocatechin-3-gallate (EGCG) in cultured rat hippocampal neurons. Int J Mol Sci 2011;12:742-754.
25.
Guo BC, Wei J, Su KH, Chiang AN, Zhao JF, Chen HY, Shyue SK, Lee TS: Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase. Mol Nutr Food Res 2015;59:646-657.
26.
Anaid Shahbazian, Petkov V, Baykuscheva-Gentscheva T, Hoeger H, Painsipp E, Holzer P, Mosgoeller W: Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery. Regul Pept 2007;139:102-108.
27.
Yap FC, Taylor MS, Lin MT: Ovariectomy-induced reductions in endothelial SK3 channel activity and endothelium-dependent vasorelaxation in murine mesenteric arteries. PLoS One 2014;9:e104686.
28.
Mansouri K, Khodarahmi R, Ghadami SA: An in vitro model for spontaneous angiogenesis using rat mesenteric endothelial cells: possible therapeutic perspective for obesity and related disorders. Pharm Biol 2013;51:974-980.
29.
Ma C, Li Y, Ma J, Liu Y, Li Q, Niu S, Shen Z, Zhang L, Pan Z, Zhu D: Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension. Hypertension 2011;58:679-688.
30.
Li Q, Niu S, Wang R, Li Y, Zhang R, Zhu D: Mechanisms that underlie the induction of vasodilation in pulmonary artery by rutin. Int Angiol 2012;31:557e564.
31.
Nakajima A, Aoyama Y, Shin EJ, Nam Y, Kim HC, Nagai T, Yokosuka A, Mimaki Y, Yokoi T, Ohizumi Y, Yamada K: Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD). Behav Brain Res 2015;289:69-77.
32.
He B, Nohara K, Park N, Park YS, Guillory B, Zhao Z, Garcia JM, Koike N, Lee CC, Takahashi JS, Yoo SH, Chen Z: The small molecule nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome. Cell Metab 2016;23:610-621.
33.
Piazza M, Guillemette JG, Dieckmann T: Dynamics of nitric oxide synthase-calmodulin interactions at physiological calcium concentrations. Biochemistry 2015;54:1989-2000.
34.
Chen J, Creed A, Chen AY, Huang H, Li Z, Rankin GO, Ye X, Xu G, Chen YC: Nobiletin suppresses cell viability through AKT pathways in PC-3 and DU-145 prostate cancer cells. BMC Pharmacol Toxicol 2014;15:59.
35.
Lau YS, Ling WC, Murugan D, Kwan CY, Mustafa MR: Endothelium-dependent relaxation effect of apocynum venetum leaf extract via Src/PI3K/Akt signalling pathway. Nutrients 2015;7:5239-5253.
36.
Vaiyapuri S, Roweth H, Ali MS, Unsworth AJ, Stainer AR, Flora GD, Crescente M, Jones CI, Moraes LA, Gibbins JM: Pharmacological actions of nobiletin in the modulation of platelet function. Br J Pharmacol 2015;172:4133-4145.
37.
Yu L, Liu Y, Qiu Z, Liu S, Gao X, Zhu D: Cellular mechanisms and intracellular signaling pathways for the modulation of eNOS in pulmonary arteries by 15-HETE. J Recept Signal Transduct Res 2012;32:87e95.
38.
Lai N, Lu W, Wang J: Ca2+ and ion channels in hypoxia-mediated pulmonary hypertension. Int J Clin Exp Pathol 2015;8:1081-1092.
39.
Ng LC, Wilson SM, McAllister CE, Hume JR: Role of InsP3 and ryanodine receptors in the activation of capacitative Ca2+ entry by store depletion or hypoxia in canine pulmonary arterial smooth muscle cells. Br J Pharmacol 2007;152:101-111.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.